查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1829133

股骨通路器械市場（按器械類型、鞘套尺寸、應用、最終用戶和材料）－全球預測，2025-2032

Femoral Access Devices Market by Device Type, Sheath Size, Application, End User, Material - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年股動脈通路設備市場規模將成長至 46.6 億美元，複合年成長率為 11.48%。

主要市場統計數據
基準年2024年 19.5億美元
預計2025年 21.7億美元
預測年份：2032年 46.6億美元
複合年成長率（%） 11.48%

簡要說明不斷發展的股動脈通路設備格局，其中臨床需求、設備創新和業務重點正在影響策略選擇

隨著手術複雜性、器材創新和醫療保健系統需求的不斷融合，股動脈通路器材領域正經歷著持續的演變。臨床醫生越來越需要能夠提高手術精準度並最大程度減少併發症的工具，而製造商也不斷調整產品系列和材料以滿足這些期望。同時，不斷變化的報銷框架、品質指標和醫院籌資策略正在塑造門診手術中心、診所和醫院的採購行為。因此，價值鏈上的相關人員必須將臨床優先事項與營運效率相結合，以改善患者預後並降低圍手術期和術後併發症發生率。

如今，臨床決策的促進因素包括手術有效性、設備人體工學以及介入性心臟病學、放射學、神經病學和血管外科的證據。因此，產品差異化不再在於功能性的提升，而是可證明的臨床價值、簡化的工作流程以及與更廣泛的介入設備生態系統的兼容性。為此，設備開發商正在投資材料科學、親水塗層以及先進的瓣膜和鞘套結構，以滿足臨床醫生的偏好和安全要求。這些進步正在為設備性能帶來新的期望，推動競爭格局的重新定位，並促使最終用戶仔細審查其對醫療總成本（而不僅僅是單位成本）的影響。

未來的市場參與企業需要在技術創新與監管嚴謹性和供應鏈韌性之間取得平衡。臨床應用取決於可靠的證據、在臨床環境中的易用性以及併發症發生率的顯著降低。同時，採購團隊將優先考慮能夠實現可預測供應、可擴展的供應商關係、縮短手術時間並提高患者吞吐量的產品。本介紹為轉型領域提供了一個框架，在該領域，對產品性能、相關人員參與度和營運準備度的策略投資將決定哪些組織能夠實現永續的臨床應用和付款人認可。

不斷發展的臨床實踐、聚合物和塗層創新以及護理環境的變化如何重新定義設備設計優先順序和採購行為

股動脈通路器械領域正在經歷一系列變革，這得益於臨床實踐的變革、技術進步以及對手術全期安全性的日益重視。在循環系統、神經科、放射學和血管外科領域，外科醫生正在擁抱微創手術，這種手術強調器械外形更小巧、止血控制更佳以及與成像和導航系統的無縫整合。因此，設計重點正轉向親水性塗層、適應性瓣膜系統以及鞘套幾何形狀，以減少動脈創傷並支援更廣泛的手術器械。

同時，材料創新正在重塑產品生命週期。尼龍、聚氨酯和聚四氟乙烯 (PTFE) 材料正在不斷改進，以平衡其推入性、抗扭結性和生物相容性。這種材料最佳化正在帶來更可靠的導引器鞘套和擴張器，使其在不同患者解剖結構中保持穩定的性能。因此，供應商正將研發資源投入聚合物化學和塗層技術上，以期實現觸覺響應並降低併發症發生率。多腔擴張器和專用導管導引線的出現，反映了當前手術專用器械的持續發展趨勢，旨在增強手術控制並降低併發症相關風險。

在營運方面，向門診和混合護理的轉變正在推動設備分銷和服務模式的變革。門診手術中心和門診專科診所正在尋求能夠簡化庫存管理並縮短設定時間的套件和設備套裝。因此，製造商正在探索附加價值服務，例如供應商管理庫存、手術培訓計劃以及用於設備追蹤和臨床結果監測的數位化工具。這種轉變也推動了設備製造商和醫療保健提供者之間的策略夥伴關係關係，以標準化准入策略，並共同製定促進一致結果的通訊協定。隨著這些趨勢的融合，競爭格局將有利於那些能夠證明臨床有效性、操作便利性以及降低整體圍手術期風險的機構。

評估2025年不斷變化的關稅政策和貿易動態將如何再形成籌資策略、價格談判和供應鏈彈性決策

2025年，貿易政策和關稅實施的變化將為採購股動脈通路器械和零件的組織帶來新的複雜性。針對醫療設備進口、零件和原料聚合物的關稅調整正在改變某些製造商和經銷商的成本結構，尤其是那些供應鏈面向跨境製造中心的製造商和分銷商。這些變化迫使下游相關人員重新評估籌資策略、庫存緩衝並實現經銷商多元化，以降低成本突然波動帶來的風險。

對於進口關鍵材料（例如特殊聚合物、聚四氟乙烯 (PTFE) 變體和親水塗層化學品）的製造商而言，關稅導致投入成本增加，在某些情況下甚至需要重新評估其生產佈局。因此，一些公司正在加速近岸外包和供應商整合，以保護利潤率並降低前置作業時間波動。同時，醫院和門診手術中心的採購團隊要求提高地租成本和總擁有成本的透明度，並要求供應商提供更清晰的定價促進因素明細，並展示其在整體醫療保健領域的成本節約價值。

累積影響也影響著策略定價和合約談判。大型綜合醫療系統正利用其採購規模，尋求固定價格、多年期契約，以對沖進一步的關稅波動；而規模較小的醫療機構則優先考慮靈活的採購安排，以便快速切換和替換其他產品線。此外，關稅環境正在加速圍繞產品在地化的討論，一些目標商標產品製造商正在投資區域製造能力，以減輕關稅的影響並提高供應鏈的彈性。這些變化迫使法律、監管和商業團隊更加緊密地合作，以使採購決策與不斷變化的貿易條件保持一致，並確保醫療保健的連續性。

高解析度分割分析揭示了設備架構、鞘套尺寸、臨床使用、最終用戶偏好和材料科學如何推動採用

要了解分段級性能，需要詳細了解器械類別、鞘套尺寸、臨床使用、最終用戶偏好和材料選擇。對於擴張器，多腔和單腔的區別決定了交換效率和器械相容性。對於導管導引線，親水塗層、J 型導絲和直型導絲等亞型決定了導航特性和血管通路策略。從親水到機械的止血閥選項直接影響出血控制和手術人體工學。導引鞘分為 10+、6+ 和 7-9 French 鞘管，反映了對手術器械相容性和血管創傷的考慮。

鞘套管尺寸細分同樣影響臨床決策。對於需要較大設備平台的複雜介入手術，通常選擇 10Fr 及更大的尺寸，而 6Fr 及較小的尺寸則支援診斷性血管造影術和微創介入。 7Fr-9Fr 尺寸代表了入路創傷和設備相容性之間的折衷。基於應用的細分強調了心臟病學、神經科、放射學和血管外科中設備功能與臨床工作流程之間的相互作用。心臟病學涵蓋循環系統和介入性心臟病學，其中快速止血和鞘套可操作性是優先事項。神經病學涵蓋血管造影術和介入神經放射學，強調非侵入性導航和與神經血管設備的兼容性。放射學涵蓋診斷性和介入性放射學，其中需要各種鞘套和導管導引線，血管外科涵蓋 EVAR 和周邊血管成形術，其中設備的堅固性和密封完整性至關重要。

最終用戶細分透過門診手術中心、診所和醫院來區分採用動態。門診手術中心分為心臟外科和放射科 ASC，它們需要精簡的套件和可預測的供應；診所分為門診和專科診所，它們優先考慮成本效益和易用性；醫院分為心臟病醫院和多專科醫院，它們的採購決策涉及平衡基於數量的合約和臨床試驗主導的採用。材料細分抓住了聚合物科學在儀器性能中的作用。尼龍變體（包括單絲和多絲纖維）提供不同的拉伸性能和觸覺回饋。聚氨酯亞型（例如酯和醚）平衡了柔韌性和耐化學性。 PTFE 選項（包括發泡PTFE 和標準 PTFE）有助於潤滑和減少摩擦。這些細分揭示了產品結構、尺寸、臨床背景、護理環境和材料特性如何決定規格選擇、購買標準和採用曲線。

關於報銷、監管和基礎設施因素如何影響世界主要地區的採用的策略見解

股動脈通路器材領域的區域動態反映了美洲、歐洲、中東和非洲以及亞太地區不同的醫療保健體系結構、法規環境和投資重點。在美洲，成熟的介入性心臟病學和血管外科計畫以及強大的報銷框架支持早期採用先進的器械功能和捆綁服務模式。該地區專注於臨床療效和基於價值的採購，鼓勵供應商展示降低併發症發生率的成果，並支持在真實環境中檢驗器械性能的長期臨床研究。

在整個歐洲、中東和非洲地區，監管協調工作和公共採購機制正在塑造採購週期和產品註冊策略。許多市場的醫院和醫療機構將成本控制和標準化設備處方放在首位，這推動了對兼具臨床療效和顯著成本效益的設備的需求。此外，介入神經病學和放射學的區域卓越中心正在推動更高臨床層面的創新，並影響供應商的定位和夥伴關係模式。

亞太地區市場成熟度參差不齊，診斷與介入服務能力快速擴張。新醫院基礎設施的投資、門診手術中心的成長以及心血管和神經血管手術的日益普及，正在推動股動脈通路技術的加速應用。同時，本土製造能力的提升以及對國內生產的政策激勵，正鼓勵跨國公司調整其供應鏈佈局並尋求合資企業。綜上所述，這些區域趨勢揭示了供應商如何在滿足不同監管和最終用戶期望的同時，優先考慮產品發布、臨床教育計畫和商業策略。

競爭格局審查，詳細說明塗層、閥門設計和整合服務產品的創新如何塑造供應商差異化和合作夥伴關係

股動脈通路器械領域的競爭定位正在被重新定義，其重點在於產品創新、策略夥伴關係和供應連續性。優先考慮差異化技術，例如先進的親水塗層、精密的止血瓣膜設計以及最佳化的鞘套幾何形狀以減少動脈創傷，這些技術正在確保介入科醫生的認可。許多公司也在擴展其服務組合，包括外科醫生培訓、手術清單和數據主導的結果支持，這些服務正在推動其應用並強化其臨床價值提案。

器械製造商與臨床中心之間的策略聯盟日益普遍，這使得雙方能夠共同開發協議化准入方法和上市後調查計畫。此類聯盟有助於展示實際應用效果，同時為進一步的產品改進鋪平道路。同時，一些公司正在採取營運措施來增強製造彈性，例如實現在地化生產，並與關鍵聚合物和塗層化學品的多元化供應商建立合作關係。這些措施對於緩解供應中斷並在不斷變化的關稅制度下履行合約承諾至關重要。

最後，競爭格局將取決於能否提供能夠降低醫院庫存複雜性並提高手術處理能力的整合解決方案。能夠將相容的擴張器、導管導引線、止血閥和鞘套組合成方便臨床醫生使用的套件，並輔以培訓和療效數據的公司，更有可能獲得市場青睞。成功取決於能否證明這些整合產品能夠顯著提高手術效率、安全性和臨床醫生滿意度。

可行的策略重點，以同步產品創新、製造彈性、臨床醫生參與和靈活契約，確保持久的市場領導地位

產業領導者應推行協調一致的策略，將產品創新與供應鏈韌性和臨床療效證據結合。首先，優先投資於能夠顯著減少血管創傷並改善器械操作的材料和塗層技術，並將這些創新與嚴格的上市後數據收集相結合，以檢驗臨床效益。證明併發症發生率降低和工作流程簡化對於與以療效為導向的採購委員會和付款相關人員互動至關重要。

其次，多元化製造地，確保關鍵原料的替代供應商，以降低關稅和地緣政治因素造成的成本波動風險。近岸外包和區域製造夥伴關係可以縮短前置作業時間，並支持與大型醫療系統達成長期商業協議。第三，創建以臨床醫生為中心的開發模式，提供針對特定手術的套件、實踐培訓項目和數位化工具，以追蹤設備使用情況和臨床結果。這些措施可以降低門診和門診環境中採用此技術的門檻，同時培養臨床醫師的長期忠誠度。

第四，強調商業性彈性，盡可能提供分級定價、多年期供應協議和結果掛鉤合約。這有助於採購方管理成本不確定性，並協調相關人員之間的獎勵。一些地區可能需要與國內製造商合作，或根據當地實踐模式客製化臨床證據包。透過實施這些優先事項，產業領導者可以強化其市場定位，保護淨利率，並擴大不同醫療環境中的臨床應用。

透過結合臨床醫生訪談、監管和臨床證據研究以及情境分析的強大混合方法研究途徑來獲得有意義的策略見解

本研究綜合了多條證據，並從一手和二手研究中得出結論。主要輸入包括對循環系統、神經科學、放射學和血管外科的介入臨床醫生、醫院和門診中心的採購和供應鏈負責人以及設備製造商的研發主管進行結構化訪談。這些訪談旨在收集關於設備性能、採購優先順序、臨床工作流程限制和供應鏈敏感性的實際觀點。

二次研究包括對同行評審的臨床文獻、監管核准和安全資訊、專利申請以及公開的企業資料進行系統性回顧，以揭示產品平臺和商業策略。在可行的情況下，我們檢驗了臨床登記冊和程序結果庫，以驗證器械的安全性和有效性聲明。調查方法強調將臨床醫生報告的經驗與記錄在案的臨床證據進行交叉檢驗，以減少偏見並提高見解的可靠性。

分析方法包括跨設備細分領域的比較特徵映射、關稅和供應鏈影響的情境分析，以及定性綜合，以得出切實可行的建議。我們維持資料來源的透明度，並在證據有限或不斷發展的情況下，專注於提升洞察的品質。這種方法的結論對商業性相關人員而言具有可操作性，對尋求循證指導的臨床相關人員而言也足夠嚴謹。

核心洞察整合和策略藍圖專注於臨床檢驗、供應鏈敏捷性和商業性協調，以推動持續採用

股動脈通路器材領域正處於技術進步、臨床重點和商業性策略交會的曲折點。材料和器械架構的進步使得通路技術更加安全高效，而護理環境和採購模式的轉變正在重塑器械的採購和部署方式。同時，不斷變化的貿易政策和供應鏈壓力凸顯了製造敏捷性和商業靈活性的必要性。

這些目標是：透過創新和證據產生提供可衡量的臨床價值；確保供應鏈穩健，以確保關鍵部件的持續供應；並使商業模式與購買者對治療結果和總成本的期望相一致。能夠透過將產品差異化與臨床醫生參與和靈活的合約模式相結合來實現這些目標的組織，將最有可能在醫院、門診中心和專科診所獲得持續的採用。本文提出的建議為克服該領域的短期挑戰和掌握長期機會提供了切實可行的藍圖。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 增加超音波引導下股動脈介入技術的應用以減少血管併發症
  • 加強設備製造商和介入性心臟病專家之間的合作，以客製化股動脈通路解決方案
  • 開發微創、可生物吸收的股動脈通路閉合裝置，以促進病患康復
  • 整合人工智慧驅動的影像分析，最佳化股動脈入路部位選擇與手術效率
  • 監管部門的核准加速了新型止血密封劑在股動脈穿刺治療的應用
  • 一次性預裝股動脈通路套件的需求不斷增加，以簡化導管室工作流程並減少感染

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 股動脈通路器械市場（依器械類型）

  • 擴張器
    • 多重腔
    • 單腔
  • 導管導引線
    • 親水塗層
    • J型尖頭
    • 直尖
  • 止血閥
    • 親水閥
    • 機械閥
  • 導引鞘
    • 10Fr 或更多
    • 6Fr 或更少
    • 7Fr～9Fr

9. 股動脈通路器械市場（依鞘鞘套尺寸）

  • 10Fr 或更多
  • 6Fr 或更少
  • 7Fr～9Fr

第 10 章股動脈通路器材市場（依應用）

  • 心臟病學
    • 診斷性血管造影術
    • 介入性心臟病學
  • 神經病學
    • 神經影像學
    • 介入神經放射學
  • 放射學
    • 診斷放射學
    • 介入放射學
  • 血管外科
    • EVAR
    • 周邊血管成形術

第 11 章股動脈通路器材市場（依最終用戶）

  • 門診手術中心
    • 心臟ASC
    • 放射學
  • 診所
    • 門診
    • 專科診所
  • 醫院
    • 心臟病醫院
    • 綜合醫院

第 12 章 股動脈通路裝置市場（依材料）

  • 尼龍
    • 單絲尼龍
    • 多絲纖維絲尼龍
  • 聚氨酯
    • 酯類聚氨酯
    • 醚聚氨酯
  • PTFE
    • 膨體聚四氟乙烯
    • 標準聚四氟乙烯

13. 股動脈通路器材市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 14 章。股動脈通路設備市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 股動脈通路器械市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Abbott
    • Teleflex
    • Vasorum Ltd.
    • Haemonetics
    • Cordis
    • Marine Polymer Technologies
    • Access Vascular Inc.
    • Advanced Vascular Dynamics
    • Meril Life Sciences
    • Terumo Corporation
Product Code: MRR-43676CF42AF7

The Femoral Access Devices Market is projected to grow by USD 4.66 billion at a CAGR of 11.48% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.95 billion
Estimated Year [2025] USD 2.17 billion
Forecast Year [2032] USD 4.66 billion
CAGR (%) 11.48%

A concise orientation to the evolving femoral access devices landscape where clinical demand, device innovation, and operational priorities are shaping strategic choices

The femoral access devices landscape is undergoing a period of sustained evolution as procedural complexity, device innovation, and health system imperatives converge. Clinicians increasingly demand tools that enhance procedural precision while minimizing complications, and manufacturers are adapting product portfolios and materials to meet these expectations. In parallel, evolving reimbursement frameworks, quality metrics, and hospital procurement strategies are shaping purchasing behavior across ambulatory surgical centers, clinics, and hospitals. Consequently, stakeholders across the value chain must reconcile clinical priorities with operational efficiency to deliver improved patient outcomes and reduce peri-procedural morbidity.

Today's clinical decision-making is influenced by a combination of procedural efficacy, device ergonomics, and evidence generated from interventional cardiology, radiology, neurology, and vascular surgery. As a result, product differentiation is less about incremental features and more about demonstrable clinical value, streamlined workflows, and compatibility with a broader ecosystem of interventional equipment. In response, device developers are investing in materials science, hydrophilic coatings, and refined valve and sheath architectures that respond to both clinician preferences and safety imperatives. These advances are creating new expectations for device performance, driving competitive repositioning, and prompting end users to scrutinize total cost of care implications rather than unit price alone.

Looking ahead, market participants must balance innovation with regulatory rigor and supply chain resilience. Clinical adoption will depend on robust evidence, ease of use in variable care settings, and demonstrable reductions in complication rates. Meanwhile, procurement teams will prioritize predictable supply, scalable vendor relationships, and products that enable shorter procedure times and faster patient throughput. This introduction frames a sector in transition, one where strategic investments in product performance, stakeholder engagement, and operational readiness will determine which organizations capture sustainable clinical adoption and payer support.

How clinical practice evolution, polymer and coating innovations, and care setting shifts are redefining device design priorities and procurement behaviors

The femoral access devices sector is experiencing a series of transformative shifts driven by clinical practice changes, technological advances, and heightened emphasis on perioperative safety. Operators are increasingly adopting minimally invasive approaches across cardiology, neurology, radiology, and vascular surgery, which places a premium on smaller profiles, improved hemostasis control, and devices that integrate seamlessly with imaging and guidance systems. As a result, design priorities have shifted toward hydrophilic coatings, adaptable valve systems, and sheath geometries that reduce arterial trauma and support a wider range of procedural instruments.

Simultaneously, material innovation is reshaping product lifecycles. Nylon, polyurethane, and PTFE variants are being reformulated to balance pushability, kink resistance, and biocompatibility. These material optimizations are enabling more reliable introducer sheaths and dilators that perform consistently across diverse patient anatomies. In turn, suppliers are reallocating R&D resources toward polymer chemistry and coating technologies that can deliver both tactile responsiveness and reduced complication rates. The emergence of multi-lumen dilators and specialized guidewire tip configurations reflects an ongoing trend toward task-specific instruments that enhance procedural control and reduce exchange-related risks.

Operationally, the shift toward ambulatory and hybrid care settings is prompting changes in device distribution and service models. Ambulatory surgical centers and outpatient specialty clinics demand kits and device bundles that simplify inventory management and reduce setup time. Consequently, manufacturers are exploring value-added services such as vendor-managed inventory, surgical training programs, and digital tools for device tracking and clinical outcomes monitoring. These shifts are also encouraging strategic partnerships between device companies and healthcare providers to co-develop protocols that standardize access strategies and promote consistent outcomes. As these trends coalesce, the competitive landscape will favor organizations that can demonstrate clinical effectiveness, operational convenience, and an ability to reduce overall peri-procedural risk.

Assessment of how evolving tariff policies and trade dynamics in 2025 are reshaping sourcing strategies, pricing negotiations, and supply chain resilience decisions

In 2025, changes in trade policy and tariff implementations have introduced new layers of complexity for organizations sourcing femoral access devices and components. Tariff adjustments targeting medical device imports, components, and raw polymer inputs have altered cost structures for certain manufacturers and distributors, particularly those with supply chains oriented toward cross-border manufacturing hubs. These shifts have compelled downstream stakeholders to reassess sourcing strategies, inventory buffers, and supplier diversification to mitigate exposure to sudden cost transference.

For manufacturers that import critical materials such as specialized polymers, PTFE variants, and hydrophilic coating chemicals, tariffs have translated into higher input costs and, in some cases, a re-evaluation of production footprints. As a result, several firms are accelerating nearshoring initiatives and vendor consolidation to preserve margin and reduce lead-time variability. At the same time, procurement teams within hospitals and ambulatory surgical centers are pushing for greater transparency around landed costs and total cost of ownership, challenging suppliers to provide clearer breakdowns of price drivers and to demonstrate cost-saving value across the care continuum.

The cumulative impact has also influenced strategic pricing and contract negotiations. Large integrated health systems are leveraging purchasing scale to seek fixed-price multi-year agreements that hedge against further tariff volatility, while smaller providers are prioritizing flexible procurement arrangements that allow for rapid substitution or switching to alternative product lines. Moreover, the tariff environment has accelerated conversation around product localization, with some original equipment manufacturers investing in regional manufacturing capabilities to reduce tariff exposure and improve supply chain resilience. These changes are prompting legal, regulatory, and commercial teams to collaborate more closely to align sourcing decisions with evolving trade conditions and to protect continuity of care.

High-resolution segmentation analysis revealing how device architecture, sheath dimensions, clinical application, end-user setting, and material science collectively drive adoption

Understanding segment-level performance requires a granular look at device categories, sheath dimensions, clinical applications, end-user settings, and material selection, each of which drives distinct purchasing logic and clinical value propositions. Based on device type, the market is studied across dilator, guidewire, hemostasis valve, and introducer sheath; within dilators, the distinction between multi-lumen and single lumen configurations informs exchange efficiency and device compatibility, while guidewire subtypes such as hydrophilic coated, J tip, and straight tip determine navigation characteristics and vessel access strategy. Hemostasis valve options ranging from hydrophilic valves to mechanical valves directly affect blood loss management and procedural ergonomics, and introducer sheaths segmented into 10Fr & above, 6Fr & below, and 7Fr-9Fr reflect procedural instrument compatibility and vessel trauma considerations.

Sheath size segmentation similarly frames clinical decision-making; 10Fr & above profiles are often selected for complex interventional procedures requiring larger device platforms, whereas 6Fr & below profiles support diagnostic angiography and less invasive interventions, with 7Fr-9Fr representing a compromise between access trauma and device compatibility. Application-based segmentation highlights the interplay between device features and clinical workflows across cardiology, neurology, radiology, and vascular surgery. Cardiology use encompasses diagnostic angiography and interventional cardiology where rapid hemostasis and sheath maneuverability are prioritized. Neurology covers neuroimaging and neurointervention, emphasizing atraumatic navigation and compatibility with neurovascular devices. Radiology spans diagnostic and interventional radiology with diverse sheath and guidewire requirements, and vascular surgery includes EVAR and peripheral angioplasty procedures where device robustness and seal integrity are critical.

End-user segmentation differentiates adoption dynamics across ambulatory surgical centers, clinics, and hospitals. Ambulatory surgical centers are further profiled into cardiac and radiology ASCs that demand streamlined kits and predictable supply, clinics are split into outpatient and specialty clinics that prioritize cost-effectiveness and ease of use, and hospitals are categorized into cardiac hospitals and multispecialty hospitals where procurement decisions balance volume-based contracts with clinical trial-driven adoption. Material segmentation captures the role of polymer science in device performance. Nylon variants, including monofilament and multifilament forms, offer differing tensile properties and tactile feedback. Polyurethane subtypes such as ester and ether formulations balance flexibility and chemical resistance, while PTFE options, comprising expanded and standard PTFE, contribute to lubricity and reduced friction. Together, these segmentations reveal how product architecture, sizing, clinical context, care setting, and material properties jointly determine specification choices, purchasing criteria, and adoption curves.

Regional dynamics and strategic considerations showing how distinct reimbursement, regulatory, and infrastructure factors are influencing adoption across key global regions

Regional dynamics in the femoral access devices sector reflect divergent healthcare system structures, regulatory environments, and investment priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, established interventional cardiology and vascular surgery programs paired with robust reimbursement frameworks support early adoption of advanced device features and bundled service models. This region's focus on clinical outcomes and value-based procurement encourages suppliers to demonstrate reductions in complication rates and to support long-term clinical studies that validate device performance in real-world settings.

Across Europe, the Middle East & Africa, regulatory harmonization efforts and public procurement mechanisms shape purchasing cycles and product registration strategies. Hospitals and health authorities in many markets emphasize cost containment and standardized device formularies, fostering demand for devices that combine clinical efficacy with demonstrable cost benefits. In addition, regional centers of excellence in interventional neurology and radiology drive innovation adoption in higher-acuity sites, influencing vendor positioning and partnership models.

The Asia-Pacific region is characterized by heterogeneous market maturity and rapid capacity expansion in diagnostic and interventional services. Investments in new hospital infrastructure, growth in ambulatory surgical centers, and a rising prevalence of cardiovascular and neurovascular procedures are motivating accelerated uptake of femoral access technologies. Meanwhile, local manufacturing capabilities and policy incentives for domestic production are prompting multinational firms to adapt supply chain footprints and to pursue collaborative ventures. Collectively, these regional trends shape how suppliers prioritize product launches, clinical education programs, and commercial strategies to meet diverse regulatory and end-user expectations.

Competitive landscape insights detailing how innovation in coatings, valve design, and integrated service offerings are shaping vendor differentiation and alliances

Competitive positioning in the femoral access devices arena is being redefined by product innovation, strategic partnerships, and a renewed emphasis on supply continuity. Leading device developers are prioritizing differentiated technologies-such as advanced hydrophilic coatings, refined hemostasis valve designs, and sheath geometries optimized for reduced arterial trauma-to secure preference among interventionalists. Many firms are also expanding their service portfolios to include surgeon training, procedural checklists, and data-driven outcomes support that facilitate adoption and reinforce clinical value propositions.

Strategic collaborations between device manufacturers and clinical centers are increasingly common, enabling co-development of protocolized access approaches and post-market surveillance programs. These alliances help demonstrate real-world performance while creating pathways for incremental product enhancement. At the same time, some companies are pursuing operational initiatives to shore up manufacturing resilience, including localized production and diversified supplier relationships for critical polymers and coating chemistries. Such measures are essential to mitigate supply disruptions and to preserve contract commitments under evolving tariff regimes.

Finally, the competitive landscape is shaped by the capacity to provide integrated solutions that reduce hospital inventory complexity and improve procedural throughput. Organizations that can bundle compatible dilators, guidewires, hemostasis valves, and sheaths into clinician-friendly kits, while supporting them with training and outcomes data, are likely to secure stronger in-market traction. Success will hinge on demonstrating that these integrated offerings deliver measurable improvements in procedural efficiency, safety, and clinician satisfaction.

Actionable strategic priorities to synchronize product innovation, manufacturing resilience, clinician engagement, and flexible contracting to secure durable market leadership

Industry leaders should pursue a coordinated strategy that aligns product innovation with supply chain resilience and clinical outcomes evidence. First, prioritize investments in materials and coating technologies that demonstrably reduce vascular trauma and improve device handling, and couple those innovations with rigorous post-market data collection to validate clinical benefits. Demonstrating reduced complication rates and workflow efficiencies will be pivotal when engaging with outcome-focused procurement committees and payer stakeholders.

Second, diversify manufacturing footprints and secure alternative suppliers for critical raw materials to reduce exposure to tariff-driven cost volatility and geopolitical disruptions. Nearshoring or regional manufacturing partnerships can shorten lead times and support longer-term commercial contracts with large health systems. Third, develop clinician-centric delivery models by offering procedure-specific kits, hands-on training programs, and digital tools that track device utilization and clinical outcomes. These initiatives will lower the barriers to adoption in ambulatory and outpatient settings while building long-term clinician loyalty.

Fourth, emphasize commercial flexibility by offering tiered pricing, multi-year supply agreements, and outcome-linked contracting where feasible. This will enable purchasers to manage cost uncertainty and to align incentives across stakeholders. Finally, invest in targeted regional strategies that respect local regulatory dynamics and care delivery models; in some regions this will require partnerships with domestic manufacturers or tailored clinical evidence packages that speak to regional practice patterns. By executing on these priorities, industry leaders can strengthen market positioning, protect margins, and expand clinical adoption across diverse care settings.

Robust mixed-methods research approach combining clinician interviews, regulatory and clinical evidence review, and scenario analysis to produce validated strategic insights

This research synthesizes multiple streams of evidence to ensure conclusions are grounded in both primary insight and secondary validation. Primary inputs include structured interviews with interventional clinicians across cardiology, neurology, radiology, and vascular surgery, procurement and supply chain leaders at hospitals and ambulatory centers, and R&D executives at device manufacturers. These engagements were designed to elicit practical perspectives on device performance, procurement priorities, clinical workflow constraints, and supply chain sensitivities.

Secondary research encompassed a systematic review of peer-reviewed clinical literature, regulatory approvals and safety communications, patent filings, and publicly available corporate disclosures that illuminate product pipelines and commercial strategies. Where available, clinical registries and procedure outcome repositories were consulted to triangulate claims regarding device safety and efficacy. The methodology emphasized cross-validation between clinician-reported experiences and documented clinical evidence to reduce bias and improve the reliability of insights.

Analytic techniques included comparative feature mapping across device segments, scenario analysis for tariff and supply chain impacts, and qualitative synthesis to derive actionable recommendations. Care was taken to maintain transparency around data sources and to qualify insights where evidence was limited or evolving. This approach ensures that findings are both actionable for commercial stakeholders and sufficiently rigorous for clinical audiences seeking evidence-aligned guidance.

Synthesis of core findings and a strategic roadmap emphasizing clinical validation, supply chain agility, and commercial alignment to drive sustained adoption

The femoral access devices landscape is at an inflection point where technical refinement, clinical priorities, and commercial strategy intersect. Advances in materials and device architecture are enabling safer, more efficient access techniques, while changing care settings and procurement models are reshaping how devices are purchased and deployed. At the same time, trade policy developments and supply chain pressures underscore the need for manufacturing agility and commercial flexibility.

Success in this environment will depend on a disciplined focus on three intertwined objectives: delivering measurable clinical value through innovation and evidence generation, securing supply chain robustness to ensure uninterrupted access to critical components, and aligning commercial models with purchaser expectations around outcomes and total cost of care. Organizations that can operationalize these objectives-by combining product differentiation with clinician engagement and flexible contracting-will be best positioned to capture sustained adoption across hospitals, ambulatory centers, and specialty clinics. The recommendations offered herein provide a practical roadmap to navigate the near-term challenges and to capitalize on long-term opportunities within the sector.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing adoption of ultrasound-guided femoral artery access techniques to reduce vascular complications
  • 5.2. Increasing collaboration between device manufacturers and interventional cardiologists for customized femoral access solutions
  • 5.3. Development of minimally invasive bioresorbable femoral access closure devices to enhance patient recovery
  • 5.4. Integration of AI-driven imaging analytics to optimize femoral access site selection and procedural efficiency
  • 5.5. Regulatory approvals accelerating introduction of novel hemostatic sealants for femoral arterial puncture management
  • 5.6. Emerging demand for single-use preloaded femoral access kits to streamline catheterization lab workflows and reduce infection

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Femoral Access Devices Market, by Device Type

  • 8.1. Dilator
    • 8.1.1. Multi-Lumen
    • 8.1.2. Single Lumen
  • 8.2. Guidewire
    • 8.2.1. Hydrophilic Coated
    • 8.2.2. J Tip
    • 8.2.3. Straight Tip
  • 8.3. Hemostasis Valve
    • 8.3.1. Hydrophilic Valve
    • 8.3.2. Mechanical Valve
  • 8.4. Introducer Sheath
    • 8.4.1. 10Fr & Above
    • 8.4.2. 6Fr & Below
    • 8.4.3. 7Fr-9Fr

9. Femoral Access Devices Market, by Sheath Size

  • 9.1. 10Fr & Above
  • 9.2. 6Fr & Below
  • 9.3. 7Fr-9Fr

10. Femoral Access Devices Market, by Application

  • 10.1. Cardiology
    • 10.1.1. Diagnostic Angiography
    • 10.1.2. Interventional Cardiology
  • 10.2. Neurology
    • 10.2.1. Neuroimaging
    • 10.2.2. Neurointervention
  • 10.3. Radiology
    • 10.3.1. Diagnostic Radiology
    • 10.3.2. Interventional Radiology
  • 10.4. Vascular Surgery
    • 10.4.1. EVAR
    • 10.4.2. Peripheral Angioplasty

11. Femoral Access Devices Market, by End User

  • 11.1. Ambulatory Surgical Center
    • 11.1.1. Cardiac ASC
    • 11.1.2. Radiology ASC
  • 11.2. Clinic
    • 11.2.1. Outpatient Clinic
    • 11.2.2. Specialty Clinic
  • 11.3. Hospital
    • 11.3.1. Cardiac Hospital
    • 11.3.2. Multispecialty Hospital

12. Femoral Access Devices Market, by Material

  • 12.1. Nylon
    • 12.1.1. Monofilament Nylon
    • 12.1.2. Multifilament Nylon
  • 12.2. Polyurethane
    • 12.2.1. Ester Polyurethane
    • 12.2.2. Ether Polyurethane
  • 12.3. PTFE
    • 12.3.1. Expanded PTFE
    • 12.3.2. Standard PTFE

13. Femoral Access Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Femoral Access Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Femoral Access Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abbott
    • 16.3.2. Teleflex
    • 16.3.3. Vasorum Ltd.
    • 16.3.4. Haemonetics
    • 16.3.5. Cordis
    • 16.3.6. Marine Polymer Technologies
    • 16.3.7. Access Vascular Inc.
    • 16.3.8. Advanced Vascular Dynamics
    • 16.3.9. Meril Life Sciences
    • 16.3.10. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. FEMORAL ACCESS DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. FEMORAL ACCESS DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. FEMORAL ACCESS DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTI-LUMEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTI-LUMEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTI-LUMEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTI-LUMEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTI-LUMEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTI-LUMEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SINGLE LUMEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SINGLE LUMEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SINGLE LUMEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SINGLE LUMEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC COATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC COATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC COATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC COATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC COATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC COATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY J TIP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY J TIP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY J TIP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY J TIP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY J TIP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY J TIP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY STRAIGHT TIP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY STRAIGHT TIP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY STRAIGHT TIP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY STRAIGHT TIP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY STRAIGHT TIP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY STRAIGHT TIP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC VALVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC VALVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC VALVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC VALVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC VALVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC VALVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MECHANICAL VALVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MECHANICAL VALVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MECHANICAL VALVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MECHANICAL VALVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MECHANICAL VALVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MECHANICAL VALVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC ANGIOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC ANGIOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC ANGIOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC ANGIOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC ANGIOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC ANGIOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROIMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROIMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROIMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROIMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROIMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROIMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROINTERVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROINTERVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROINTERVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROINTERVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROINTERVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROINTERVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC RADIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC RADIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC RADIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC RADIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC RADIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC RADIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY EVAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY EVAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY EVAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY EVAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY EVAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY EVAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC ASC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC ASC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC ASC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC ASC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC ASC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC ASC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY ASC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY ASC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY ASC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY ASC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY ASC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY ASC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY OUTPATIENT CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY OUTPATIENT CLINIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY OUTPATIENT CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY OUTPATIENT CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTISPECIALTY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTISPECIALTY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTISPECIALTY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTISPECIALTY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTISPECIALTY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTISPECIALTY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MONOFILAMENT NYLON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MONOFILAMENT NYLON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MONOFILAMENT NYLON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MONOFILAMENT NYLON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MONOFILAMENT NYLON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MONOFILAMENT NYLON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTIFILAMENT NYLON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTIFILAMENT NYLON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTIFILAMENT NYLON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTIFILAMENT NYLON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTIFILAMENT NYLON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTIFILAMENT NYLON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ESTER POLYURETHANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ESTER POLYURETHANE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ESTER POLYURETHANE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ESTER POLYURETHANE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ESTER POLYURETHANE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ESTER POLYURETHANE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ETHER POLYURETHANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ETHER POLYURETHANE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ETHER POLYURETHANE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ETHER POLYURETHANE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 303. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ETHER POLYURETHANE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 304. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ETHER POLYURETHANE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, 2025-2032 (USD MILLION)
  • TABLE 307. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 308. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 309. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 310. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL FEMORAL ACCESS D